Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSOM factorial trial of cotrimoxazole and povidone-iodine added to standard ear care
ACTRN12614000234617Phase 4Completed
- Sponsor
- Menzies School of Health Research
- Start
- Mar 2015
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of trimethoprim + sulfamethoxazole, povidone-iodine and ciprofloxacin in chronic suppurative otitis media (CSOM), sponsored by Menzies School of Health Research. Primary endpoint: Clinical failure at 16 weeks. Started Mar 2015; status: completed.
02
Drugs
trimethoprim + sulfamethoxazolepovidone-iodineciprofloxacin
03
Conditions
chronic suppurative otitis media (CSOM)
Beyond the preview
Go deeper on ACTRN12614000234617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000234617.